Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
E-pub ahead of print

Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients with Aortic Stenosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A method for modelling the oxyhaemoglobin dissociation curve at the level of the cerebral capillary in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Survival in patients with scintigraphic evidence of pulmonary thromboembolism 12 weeks after double lung transplantation

    Research output: Contribution to journalLetterResearchpeer-review

  3. Ventilation-perfusion SPECT versus CTPA in young adult females with suspected pulmonary embolism

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  4. High low-density lipoprotein levels and high risk of aortic stenosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Emilie Ramberg
  • Anders M Greve
  • Ronan M G Berg
  • Ahmad Sajadieh
  • Steen Bendix Haugaard
  • Ronnie Willenheimer
  • Michael H Olsen
  • Kristian Wachtell
  • Olav W Nielsen
View graph of relations

Asymptomatic aortic stenosis (AS) is a frequent condition that may cause hyponatremia due to neurohumoral activation. We examined if hyponatremia heralds poor prognosis in patients with asymptomatic AS, and whether AS in itself is associated with increased risk of hyponatremia. The study question was investigated in 1,677 individuals that had and annual plasma sodium measurements in the SEAS (Simvastatin and Ezetimibe in AS) trial; 1,873 asymptomatic patients with mild-moderate AS (maximal transaortic velocity 2.5 to 4.0 m/s) randomized to simvastatin/ezetimibe combination versus placebo. All-cause mortality was the primary endpoint and incident hyponatremia (P-Na + <137 mmol/L) a secondary outcome. At baseline, 4% (n = 67) had hyponatremia. After a median follow-up of 4.3 (interquartile range 4.1 to 4.6) years, 140 (9%) of those with initial normonatremia had developed hyponatremia, and 174 (10%) had died. In multiple regression Cox models, both baseline hyponatremia (hazard ratio [HR] 2.1, [95% confidence interval 1.1 to 3.8]) and incident hyponatremia (HR 1.9, [95% confidence interval 1.0 to 3.4], both p ≤ .03) was associated with higher all-cause mortality as compared with normonatremia. This association persisted after adjustment for diuretics as a time-varying covariate. Higher N-terminal pro b-type natriuretic peptide levels and lower sodium levels at baseline was associated with higher risk of incident hyponatremia. Conversely, assignment to simvastatin/ezetimibe protected against incident hyponatremia. In conclusion, both prevalent and incident hyponatremia associate with increased mortality in patients with AS. The prevalence of hyponatremia is around 4% and the incidence about 2% per year, which is comparable to that of older adults without AS.

Original languageEnglish
JournalThe American journal of cardiology
Publication statusE-pub ahead of print - 19 Nov 2020

Bibliographical note

Copyright © 2020 Elsevier Inc. All rights reserved.

ID: 61308060